Havencrest Healthcare Partners a Dallas-based, healthcare-focused private equity firm, today announces the close of its debut fund, Havencrest Healthcare Partners, LP.  The closing was held on June 14, 2017.

“We believe the powerful, long-term, and secular growth trends present in today’s healthcare industry are creating tremendous investment opportunities to build leading companies focused on higher-quality and lower-cost health care,” said Christopher W. Kersey, M.D., M.B.A., Havencrest’s founding managing partner.

Havencrest is honored to partner with a world-class cadre of investors and senior advisors that includes leading healthcare operators, entrepreneurs and public policy experts.

Havencrest focuses on buyouts and majority recapitalizations as well as minority growth equity financings for high-growth private companies with $3M - $15M in annualized EBITDA requiring between $10M - $30M in equity capital.

By focusing on companies in healthcare services, technology-enabled healthcare services and medical products, Havencrest will capitalize on growth trends, demographic changes and regulatory tailwinds to identify and invest in market leaders in America’s largest industry.